【摘 要】
:
Background: This study investigated and quantified the dosimetric impact of the distance from the tumor to the spinal cord and fractionation schemes for patients who received stereotactic body radiati
【机 构】
:
Department of Radiation Oncology, Chinese PLA General Hospital, Beijing,P.R.China;Department of Radi
论文部分内容阅读
Background: This study investigated and quantified the dosimetric impact of the distance from the tumor to the spinal cord and fractionation schemes for patients who received stereotactic body radiation therapy (SBRT) and hypofractionated simultaneous integrated boost (HF-SIB).Material/Methods: Six modified planning target volumes (PTVs) for 5 patients with spinal metastases were created by artificial uniform extension in the region of PTV adjacent spinal cord with a specified minimum tumor to cord distance (0-5 mm).The prescription dose (biologic equivalent dose, BED) was 70 Gy in different fractionation schemes (1, 3, 5, and 10 fractions).For PTV V100, Dmin, D98D95and D1spinal cord dose, conformity index (CI), V30 were measured and compared.Results: PTV-to-cord distance influenced PTV V100Dmin D98and D95and fractionation schemes influenced Dmin and D98with a significant difference.Distances of ≥2 mm, ≥1 mm, ≥1 mm, and ≥0 mm from PTVto spinal cord meet dose requirements in 1, 3, 5, and 10 fractionations, respectively.Spinal cord dose, CI, and V30 were not impacted by PTV-to-cord distance and fractionation schemes.Conclusions: Target volume coverage, Dmin, D98and D95 were directly correlated with distance from the spinal cord for spine SBRT and HF-SIB.Based on our study, ≥2 mm, ≥1 mm, ≥1 mm, and ≥0 mm distance from PTV to spinal cord meets dose requirements in 1, 3, 5 and 10 fractionations, respectively.
其他文献
放疗是治疗宫颈癌的主要方法,卵巢做为危及器官暴露于电离辐射可造成其功能下降,影响患者的生活质量.调强技术较三维适形技术可进一步降低正常组织和危及器官的受量,现将容积调强计划和HT计划进行对比,研究两者的剂量学差异及对卵巢保护的优劣.
目的:以一例全骨髓照射患者为例介绍空军总医院肿瘤放疗科应用螺旋断层放疗技术实施全骨髓照射(TMI)治疗的操作流程及相关注意事项,以及简单分析全骨髓照射(TMI)相比于全身照射(TBI)的剂量特点和优势.方法:患者为以12岁女童,TMI治疗方案总处方剂量12Gy,单次4Gy/d,分3天完成.患者依次行固定器制作、CT扫描、靶区勾画、治疗计划设计及优化和治疗实施等过程最终完成治疗.剂量验证采用ArcC
将调强治疗布野方式应用于TOMO(Helical)计划设计中,比较其剂量学优势及临床可行性.本次研究通过对偏心肿瘤、椎体转移肿瘤的计划比对可见,将此类肿瘤IMRT传统布野方式应用于TOMO计划优化中可有效控制低剂量分布范围,降低不必要的受照区域,但在相同优化参数下至少增加1/3的治疗时间及延长近1.5倍的单圈治疗时长。计划设计时对调制因子(MF)和螺距比(PICTH)的优化调整,可保证具有相同计划
确定IC Profiler用于测量加速器照射野常规剂量学质控项目的准确性.用IC Profiler测出的射野平坦度、对称性及inline, crossline方向的半影宽度其准确性与三维水箱测出的结果一致,但在两对角线方向上还存在误差,故在对加速器进行照射野常规剂量学质控时,可用IC Profiler查看inline, crossline方向的数据,但若需知晓对角线方向的剂量学特性,建议以三维水箱
分析二维半导体矩阵TomoDose检测螺旋断层直线加速器射野离轴剂量分布特性的准确性.二维半导体矩阵TomoDose测量的射野离轴剂量分布曲线与三维水箱BAH电离室扫描结果具有较好的一致性,可以用于螺旋断层直线加速器的射野离轴剂量分布的日常检测。
验证食管癌颈胸联合野单中心上下半野调强放疗技术的可行性,为其临床应用提供剂量学依据.食管癌颈胸联合野长靶区单中心上下分野调强放射治疗技术满足临床要求,可以应用于临床治疗。食管癌颈胸联合野长靶区单中心上下分野调强放疗与传统的两个中心做法相比,只需一次摆位,减少了放疗技师的摆位时间和患者的治疗时间。单中心上下分野调强技术提高了靶区剂量,同时又避免了肺过多的低剂量照射,很好的满足了临床剂量要求。
分析探讨Mapchcek2高级功能在AAPM TG142报告中的临床应用,建立基于Mapchcek2的质控流程与方法.
为保证病人、工作人员、公众以及场所的辐射安全,治疗过程的顺利执行以及物理剂量的精确实施,现针对宫颈癌近距离治疗过程中所涉及到的质控内容进行简要介绍.
分别采用EPID和Mapcheck2验证MLC步进模式下的到位精度,比较两者的方法的差异及结果的精度.
Background: This study evaluated the impact of the distance from planning target volume (PTV) to spinal cord on planning dosimetry of stereotactic body radiation therapy (SBRT) in patients with isolat